2-substituted-1(4)-aryl piperazines and the process for their preparation
    1.
    发明授权
    2-substituted-1(4)-aryl piperazines and the process for their preparation 失效
    2-取代-1(4) - 芳基哌嗪及其制备方法

    公开(公告)号:US5051422A

    公开(公告)日:1991-09-24

    申请号:US408020

    申请日:1989-09-15

    CPC分类号: C07D403/12 C07D241/04

    摘要: This invention relates to novel 2-substituted-1(4)-aryl piperazines and to a process for their preparation. The compounds of this invention have been found to have cardiovascular, primarily antiarrhythmic effects and are of the following general formula I ##STR1## wherein R is hydrogen, lower alkyl or benzyl; and R.sub.1 and R.sub.2 are the same or independently hydrogen, lower alkyl, lower alkoxy or halogen;Z is ##STR2## --NR.sub.3 --CH.sub.2 --, --OCH.sub.2 --, --NR.sub.3 --, --O-- or --NR.sub.3 SO.sub.2 -- andQ is (C.sub.1 -C.sub.4) alkyl--SO.sub.2 --NR.sub.4 -- or ##STR3## R.sub.3 is hydrogen, lower alkyl, allyl or loweralkoxyloweralkyl; and included in the descriptors of the compounds of Formula I is the proviso that when R.sub.4 is methyl then ##STR4## must be in the 2 position of Formula I.

    摘要翻译: 本发明涉及新的2-取代-1(4) - 芳基哌嗪及其制备方法。 已经发现本发明的化合物具有心血管,主要是抗心律失常作用,并且具有以下通式I其中R是氢,低级烷基或苄基; 且R 1和R 2相同或独立地为氢,低级烷基,低级烷氧基或卤素; Z是-NR 3 -CH 2 - , - OCH 2 - , - NR 3 - , - O-或-NR 3 SO 2 - ,Q是(C 1 -C 4)烷基-SO 2 -NR 4 - 或R 3是氢, ,烯丙基或低级烷氧基低级烷基; 并且包括在式I化合物的描述中的条件是当R 4为甲基时,则必须在式I的2位。

    Quinuclidines and quinuclidinium salts as antiarrhythmic agents
    7.
    发明授权
    Quinuclidines and quinuclidinium salts as antiarrhythmic agents 失效
    奎宁和喹喔啉盐作为抗心律不齐药

    公开(公告)号:US4599344A

    公开(公告)日:1986-07-08

    申请号:US666788

    申请日:1984-10-31

    IPC分类号: C07D453/02 A61K31/445

    CPC分类号: C07D453/02

    摘要: Novel quinuclidines, their acid addition, quaternary ammonium and inner salts are described. Also provided is the method of using these compounds as antiarrhythmic agents and pharmaceutical formulations containing such compounds.

    摘要翻译: 描述了新的奎宁子,它们的酸加成盐,季铵盐和内盐。 还提供了使用这些化合物作为抗心律失常剂的方法和含有这些化合物的药物制剂。

    N-(aminoalkyl)-substituted(N or C
alkyl)-aryl-4(methylsulfonylamino)benzamides
    8.
    发明授权
    N-(aminoalkyl)-substituted(N or C alkyl)-aryl-4(methylsulfonylamino)benzamides 失效
    N-(氨基烷基) - 取代(N或C烷基) - 芳基-4(甲基磺酰基氨基)苯甲酰胺

    公开(公告)号:US4920116A

    公开(公告)日:1990-04-24

    申请号:US283712

    申请日:1988-12-13

    IPC分类号: C07D295/13 G03G5/06

    摘要: N-(aminoalkyl)-substituted(N or C alkyl)-aryl-4-(methylsylfonylamino)benzamides of the formula ##STR1## wherein R is C.sub.1 -C.sub.4 straight chain alkyl, one of R.sub.1, R.sub.2 and R.sub.3 is a phenyl or naphthyl group and the others are hydrogen, --NR.sub.4 R.sub.5 is a secondary or teritary amino group, X and X.sub.1 are hydrogen or alkyl and n is 0 or 1, are useful as antiarrhythmic agents in the treatment of cardiac arrhythmias especially as combination Class I/Class III agents.

    摘要翻译: 式(Ia)的N-(氨基烷基) - 取代的(N或C烷基) - 芳基-4-(甲基磺酰基氨基)苯甲酰胺其中R是C1-C4直链烷基,R1,R2和R3之一是苯基或萘基 基团,其余是氢,-NR4R5是次级或分离的氨基,X和X1是氢或烷基,n是0或1,可用作治疗心律失常的抗心律不齐剂,特别是作为I / III类 代理商